News

RepliCel Forms Clinical Advisory Board to Support the Development of RCT-01 for the Treatment of Chronic Tendinosis

10 years ago Oct 29, 2013

VANCOUVER, BC – October 30, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...

Stem Cell Technology Used in Search for the Holy Grail of Hair Treatments: a Cure for Baldness

10 years ago Oct 27, 2013

Hisae Nakamura, director of research and development for RepliCel, with a device used to inject...

RepliCel Announces Stock Option Grant

11 years ago Sep 05, 2013

VANCOUVER, BC – September 6, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...

RepliCel Retains Westwicke Partners as Investor Relations Counsel

11 years ago Sep 03, 2013

VANCOUVER, BC – September 4, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...

RepliCel Announces Closing of Private Placement

11 years ago Jul 18, 2013

VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

Replicel and Shiseido Complete Collaboration and Technology Transfer Agreement on Technology for Treating Pattern Baldness

11 years ago Jul 10, 2013

VANCOUVER, BC – July 11, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License

11 years ago May 28, 2013

Tokyo, Japan and Vancouver, Canada – May 29, 2013 – RepliCel Life Sciences Inc. (the...

Dr. Jerry Shapiro to Present RepliCel Data to European Academy of Dermatology and Venereology in Poland

11 years ago May 22, 2013

VANCOUVER, BC – May 23, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel Announces Closing of Private Placement

11 years ago May 20, 2013

VANCOUVER, BC – May 21, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise

11 years ago Apr 29, 2013

VANCOUVER, BC – April 30, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel Presents Further Clinical Data and Corporate Update at its Annual General Meeting of Shareholders

11 years ago Apr 29, 2013

VANCOUVER, BC – June 11, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

Vancouver Biotech Receives U.S. Patent for Hair Regeneration Technology

11 years ago Apr 18, 2013

By Emma Crawford, Thu Apr 18, 2013 10:53am PSTVancouver biotech RepliCel Life Sciences Inc. (OTCQB:REPCF)(CNSX:RP)...

RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for its Hair Regeneration Technology

11 years ago Apr 12, 2013

VANCOUVER, BC – April 18, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel Announces Closing of Private Placement

11 years ago Apr 09, 2013

VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel to Present at the 11th Annual BioPartnering North America Conference

11 years ago Feb 23, 2013

Vancouver Convention Centre, Vancouver, BC, February 24-26th, 2013 VANCOUVER, BC – February 19th 2013 –...

RepliCel Announces Re-Pricing of Warrants

11 years ago Feb 07, 2013

VANCOUVER, BC – February 8, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel to Meet with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Process

11 years ago Feb 03, 2013

Phase II Dose Ranging Trial Planned for 2013 VANCOUVER, BC – February 4, 2013 –...

RepliCel Completes First Pre-Filing Review with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Pro

11 years ago Nov 06, 2012

Phase II Dose Ranging Trial on its Hair Cell Replication Technology Expected to Commence Mid-2013...

RepliCel’s Common Shares Listed on CNSX

12 years ago Sep 30, 2012

VANCOUVER, BC – October 1, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel’s Chief Medical Officer to Present at 21st European Academy of Dermatology & Venereology Congress

12 years ago Sep 25, 2012

VANCOUVER, BC – September, 26, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.